NCT05203354View on ClinicalTrials.gov

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

May 1, 2021

Study Completion Date

August 15, 2021

Conditions

Psoriasis

Interventions

RADIATION

Narrowband Ultraviolet B

patients will exposed to sessions of NB-UVB phototherapy twice weekly for 3 months

DRUG

Acitretin

patients will received acitretin in dose 0.5-1 mg/kg daily for 3 months

Trial Locations (1)

81528

Faculty of medicine - Aswan university, Aswān

All Listed Sponsors

lead

Mahmoud Ahmed Ali Ahmed

OTHER

NCT05203354 - Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin | Biotech Hunter | Biotech Hunter